Pre-loader

Life Sciences & Pharmaceutical Litigation

Our lawyers understand the science and know how to win complex disputes.

Tyr is made up of trial-tested litigators. We know how to win complex cases. Our intellectual property litigators also know the science and understand the complex regulatory framework in which our clients operate. Many of our trial lawyers hold degrees in biological or chemical life sciences disciplines.

We represent pharmaceutical, biotechnology, medical device, and other life sciences companies from around the world. We also regularly provide coordinated domestic, cross-border and global litigation strategies to protect US-based and multi-national corporations.

We represent clients in an array of pharmaceutical and life sciences litigation, including patent infringement and validity actions as well as disputes and judicial reviews of decisions on patent listing, data protection, regulatory approvals and processes, pricing, and access-to-information. We also advise clients on drug pricing matters including representing clients in investigations and hearings before the Patented Medicine Prices Review Board.

Our litigators have acted on some of Canada's leading patent trials and have extensive experience litigating cases under the Patented Medicines (Notice of Compliance) Regulations including damages actions resulting therefrom.

Our litigators are repeatedly recognized for their life sciences expertise in Chambers, Lexpert, Benchmark, Best Lawyers, and Who's Who Legal.

Related Areas of Practice

Representative Cases

Click on a case to view details.
Allergan Inc. v. Juno Pharmaceuticals Corp. re: LUMIGAN RC® Bausch Health, Canada et al. ats Pharmascience Inc. re: SUBLINOX® Bausch Healthcare Co. Inc., Valeant Canada S.E.C. et al. ats The Province of British Columbia (Canadian Opioid Class Actions) Bristol-Myers Squibb Canada Co. v. Mylan Pharmaceuticals ULC re: SUSTIVA® Bristol-Myers Squibb Canada Co. v. Pharmascience Inc. re: ELIQUIS® Eli Lilly Canada ats Apotex Inc. re: ADCIRCA® Eli Lilly Canada Inc. et al. ats Apotex Inc. re: ZYPREXA® Eli Lilly Canada Inc. et al. ats Teva Canada Limited re: FORTEO® Gilead Sciences Inc. et al. ats AbbVie Inc. re: HARVONI® Gilead Sciences Inc. et al. ats Idenix Pharmaceuticals re: SOVALDI® GlaxoSmithKline Inc. et al. ats Apotex Inc. and Pharmascience Inc. et al. re: VALTREX® GlaxoSmithKline Inc. et al. ats Apotex Inc. et al. re: AZT® Janssen Inc. ats Teva Canada Limited re: VELCADE® Janssen Inc. ats AbbVie Corporation re: STELARA® Janssen Inc. et al. v. Natco re: IMBRUVICA® Janssen Inc. et al. v. Apotex Inc. re: OPSUMIT® Janssen Inc. et al. v. Generic Medical Partners Inc. re: OPSUMIT® Janssen Inc. et al. v. Hospira Healthcare Corporation re: REMICADE® Janssen Inc. et al. v. JAMP Pharma Corporation re: OPSUMIT® Janssen Inc. et al. v. Sandoz Canada Inc. re: OPSUMIT® Janssen Inc. et al. v. Sandoz Canada Inc. re: UPTRAVI® Janssen Inc. et al. v. Sandoz re: IMBRUVICA® Janssen Inc. v. Apotex Inc. re: PREZISTA® Janssen Pharmaceutica NV v Apotex Inc. re: ODEFSEY® Merck Sharp & Dohme Corp. v. Pharmascience Inc. re: JANUVIA® Patient assistive device company Pfizer Canada Inc. et al. ats Apotex Inc. re: NORVASC® Pfizer Canada Inc. et al. ats Teva Canada Inc. re: NORVASC® Pfizer Inc. et al. ats Apotex Inc. and Teva Canada Inc. re: VIAGRA® Pfizer Inc. et al. ats Apotex Inc. re: ACCUPRIL® Pfizer Inc. et al. ats Apotex Inc. re: LIPITOR® Valeant Canada LP v. Generic Partners Canada Inc. re: GLUMETZA® Various pharmaceutical companies Wyeth LLC ats Merck, Sharp & Dohme re: PREVNAR®